Hot Features
プレミアム
Ocular Therapeutix Inc (OCUL)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | Dr. Nadia K. WaheedChief Medical Officer | -14.83k | 122.63k | 売り | 8.27 | 94.17k | -13.60% |
| 2026-05-28 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -394.70k | 0.00 | Other Disposition | - | 744.90k | -34.63% |
| 2026-05-26 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -21.16k | 173.48k | 売り | 8.20 | 744.90k | -2.76% |
| 2026-05-26 | Dr. Peter K. KaiserChief Development Officer | -2.97k | 24.33k | 売り | 8.20 | 89.81k | -3.20% |
| 2026-05-26 | Dr. Jeffrey S. HeierChief Scientific Officer | -3.02k | 24.75k | 売り | 8.20 | 174.57k | -1.70% |
| 2026-05-26 | Mr. Sanjay NayakChief Strategy Officer | -1.86k | 15.24k | 売り | 8.20 | 169.82k | -1.08% |
| 2026-04-09 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -394.70k | 0.00 | Other Disposition | - | 694.81k | -36.23% |
| 2026-02-23 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -20.06k | 166.06k | 売り | 8.28 | 623.56k | -3.12% |
| 2026-02-23 | Dr. Jeffrey S. HeierChief Scientific Officer | -3.06k | 25.31k | 売り | 8.28 | 177.59k | -1.69% |
| 2026-02-23 | Dr. Peter K. KaiserChief Development Officer | -2.81k | 23.27k | 売り | 8.28 | 52.03k | -5.12% |
| 2026-02-23 | Mr. Sanjay NayakChief Strategy Officer | -1.76k | 14.56k | 売り | 8.28 | 158.30k | -1.10% |
| 2026-02-20 | Dr. Nadia K. WaheedChief Medical Officer | -3.51k | 27.17k | 売り | 7.74 | 61.78k | -5.38% |
| 2026-02-20 | Dr. Richard L. LindstromIndependent Director | 60.23k | 461.35k | 買い | 7.66 | 232.93k | 34.87% |
| 2026-02-12 | Mr. Donald NotmanCOO (Leave of Absence) | -11.45k | 103.47k | 売り | 9.04 | 182.68k | -5.90% |
| 2026-02-12 | Mr. Sanjay NayakChief Strategy Officer | -10.35k | 93.55k | 売り | 9.04 | 160.05k | -6.07% |
| 2026-02-12 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -124.88k | 1.13M | 売り | 9.04 | 643.62k | -16.25% |
| 2026-02-12 | Dr. Nadia K. WaheedChief Medical Officer | -7.86k | 71.08k | 売り | 9.04 | 65.29k | -10.75% |
| 2026-02-02 | Mr. Donald NotmanCOO (Leave of Absence) | -11.49k | 101.40k | 売り | 8.54 - 9.14 | 155.79k | -6.87% |
| 2025-11-24 | Mr. Sanjay NayakChief Strategy Officer | -1.88k | 22.61k | 売り | 12.04 | 133.40k | -1.39% |
| 2025-11-24 | Dr. Peter K. KaiserChief Development Officer | -3.01k | 36.14k | 売り | 12.02 | 73.84k | -3.91% |
| 2025-11-24 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -19.53k | 235.14k | 売り | 12.04 | 351.84k | -5.26% |
| 2025-11-26 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -49.75k | 0.00 | Other Disposition | - | 351.84k | -12.39% |
| 2025-11-24 | Dr. Jeffrey S. HeierChief Scientific Officer | -3.47k | 41.77k | 売り | 12.04 | 128.35k | -2.63% |
| 2025-11-05 | Dr. Namrata SarojChief Business Officer | -25.87k | 277.79k | 売り | 10.74 | 174.14k | -12.93% |
| 2025-10-08 | Mr. Todd D.C. AndermanChief Legal Officer & Corporate Secretary | -11.13k | 137.37k | 売り | 12.34 | 87.57k | -11.28% |
| 2025-10-02 | Dr. Peter K. KaiserChief Development Officer | -9.65k | 106.47k | 売り | 11.03 | 66.66k | -12.65% |
| 2025-10-02 | Dr. Jeffrey S. HeierChief Scientific Officer | -10.50k | 115.94k | 売り | 11.04 | 121.63k | -7.95% |
| 2025-09-09 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -49.75k | 0.00 | Other Disposition | - | 300.12k | -14.22% |
| 2025-09-02 | Mr. Donald NotmanCOO (Leave of Absence) | -1.07k | 13.25k | 売り | 12.43 | 126.84k | -0.83% |
| 2025-08-25 | Dr. Peter K. KaiserChief Development Officer | -3.01k | 36.25k | 売り | 12.04 | 42.98k | -6.55% |
| 2025-08-25 | Mr. Sanjay NayakChief Strategy Officer | -1.89k | 22.70k | 売り | 12.04 | 128.59k | -1.44% |
| 2025-08-25 | Dr. Jeffrey S. HeierChief Scientific Officer | -3.06k | 36.88k | 売り | 12.04 | 98.80k | -3.01% |
| 2025-08-25 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -21.49k | 258.79k | 売り | 12.04 | 300.12k | -6.68% |
| 2025-04-28 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -250.36k | 0.00 | Other Disposition | - | 250.36k | -50.00% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
